One explanation may be that clinician attitudes to diagnosing prostate cancer were evolving – i.e., clinicians became more concerned with over-diagnosing prostate cancer and were waiting for higher prostate-specific antigen test scores before conducting biopsies. The gene discussed is KLK3; the disease is prostate cancer.